If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,045.00    31.00 (1.03%)
Bid:
3,033.00
Ask:
3,036.00
Spread: 3.00 (0.099%)
Market Cap: £4.24b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Q3 Trading Statement

28 Oct 2010 07:00

RNS Number : 1272V
Croda International PLC
28 October 2010
 



28 October 2010

 

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2010, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report continued strong progress in the third quarter, driven by significant sales growth building on a robust 2009 performance.

 

For the three months ended 30 September 2010, Group sales from continuing operations increased 18.6% to £255.3m (2009: £215.2m). Sales volumes increased by 12.1% compared to 2009. More importantly the two year volume trend versus 2008 (which takes out most of the effect of the recession) is showing increasing momentum:

 

2010 v 2009

2009 v 2008

2 year growth

Q1:

+30%

-28%

-6%

Q2:

+26%

-24%

-4%

Q3:

+12%

-6%

+5%

 

Quarter three is normally a quieter trading period than either of the first two quarters. Operating profit from continuing operations increased 47.1% to £48.7m (2009: £33.1m). Interest costs fell, due to lower borrowings, resulting in continuing pre-tax profit increasing 56.8% to £47.5m (2009: £30.3m).

 

Year-to-date, the pre-tax profit from continuing operations is up 87.6% at £143.7m (2009: £76.6m).

 

In quarter three Consumer Care has continued to trade robustly with big increases in sales (+15.4%) and operating profit (+32.5%) and improved margins versus the corresponding quarter in 2009. All business areas were ahead of 2009 with Crop Care delivering a particularly strong performance.

 

In Industrial Specialities the third quarter trading improvement versus 2009 is more marked with sales and profits up 22.1% and 89.4% respectively. Again, all business areas were ahead of 2009 in both sales and profits.

 

The quarter also saw a significant reduction in net debt with a cash inflow of £32.2m before adverse currency translation of £3.2m, bringing the year-to-date figure to £47.4m with favourable currency translation taking the total net debt reduction to £47.8m for the nine months. At the end of September, net debt stood at £240.7m.

 

Croda continues to trade strongly and we expect to report further year on year progress in the final quarter of 2010 and into 2011."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

Financial Dynamics

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 542 303 and quote "Croda International" to gain access to the call.

 

 

 

£m

Q3

9 months

2010

2009

2010

2009

Consumer Care

128.2

111.1

392.5

343.5

Industrial Specialities

127.1

104.1

379.9

280.1

Continuing turnover

255.3

215.2

+18.6%

772.4

623.6

+23.9%

Consumer Care

32.6

24.6

103.8

77.4

Industrial Specialities

16.1

8.5

45.7

9.4

Continuing operating profit

48.7

33.1

+47.1%

149.5

86.8

+72.2%

Operating margin

19.1%

15.4%

19.4%

13.9%

Interest

(1.2)

(2.8)

(5.8)

(10.2)

Continuing pre tax profit

47.5

30.3

+56.8%

143.7

76.6

+87.6%

 

Analysis of Q3 turnover uplift

Price/mix

+4.4%

Volume

+12.1%

Currency translation

+2.1%

Continuing turnover increase

+18.6%

 

 

 

Industrial Specialities turnover for 2009 and 2010 restated to include final adjustments relating to the discontinued Emmerich business.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAKEXADNEFFF
Date   Source Headline
4th Aug 20253:21 pmRNSDirector/PDMR Shareholding
4th Aug 202511:03 amRNSDirector/PDMR Shareholding
4th Aug 20258:46 amRNSDirector/PDMR Shareholding
1st Aug 20253:43 pmRNSDirector/PDMR Shareholding
1st Aug 20251:31 pmRNSDirector/PDMR Shareholding
31st Jul 20253:42 pmRNSDirector/PDMR Shareholding
29th Jul 20252:33 pmRNSDirector/PDMR Shareholding
29th Jul 20252:31 pmRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSResults for the six months ended 30 June 2025
16th Jul 20252:08 pmRNSDirector/PDMR Shareholding
12th Jun 202510:01 amRNSDirector/PDMR Shareholding
6th Jun 20258:45 amRNSCorporate Broker Appointment
2nd Jun 20258:44 amRNSDirector/PDMR Shareholding
29th May 20258:57 amRNSDirector/PDMR Shareholding
13th May 20253:48 pmRNSDirector/PDMR Shareholding
6th May 20252:26 pmRNSDirector/PDMR Shareholding
24th Apr 202511:40 amRNSResult of AGM
23rd Apr 20257:00 amRNSFirst quarter 2025 sales update
11th Apr 20252:33 pmRNSDirector/PDMR Shareholding
11th Apr 20252:06 pmRNSDirector/PDMR Shareholding
7th Apr 202511:14 amRNSDirector/PDMR Shareholding
4th Apr 20253:49 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:47 pmRNSDirector/PDMR Shareholding
31st Mar 202512:14 pmRNSDirector/PDMR Shareholding
27th Mar 20259:57 amRNSDirector Declaration
25th Mar 202512:30 pmRNSDirector/PDMR Shareholding
25th Mar 202512:27 pmRNSDirector/PDMR Shareholding
25th Mar 202512:26 pmRNSDirector/PDMR Shareholding
25th Mar 202512:23 pmRNSDirector/PDMR Shareholding
25th Mar 202512:21 pmRNSDirector/PDMR Shareholding
25th Mar 202512:21 pmRNSDirector/PDMR Shareholding
25th Mar 202512:17 pmRNSDirector/PDMR Shareholding
25th Mar 202512:14 pmRNSDirector/PDMR Shareholding
13th Mar 202512:38 pmRNSAnnual Financial Report
11th Mar 20252:54 pmRNSDirector/PDMR Shareholding
11th Mar 20257:13 amRNSDirector Declaration
10th Mar 202510:42 amRNSHolding(s) in Company
3rd Mar 20253:49 pmRNSDirectorate Change
25th Feb 202511:30 amRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSFinal Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:19 pmRNSDirector/PDMR Shareholding
11th Dec 20243:09 pmRNSDirector/PDMR Shareholding
11th Dec 20241:54 pmRNSDirector/PDMR Shareholding
9th Dec 20242:36 pmRNSHolding(s) in Company
29th Nov 202412:12 pmRNSHolding(s) in Company
20th Nov 20241:42 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSDirectorate Change
12th Nov 20242:47 pmRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSThird quarter 2024 sales update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.